Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-14-005102
Filing Date
2014-03-12
Accepted
2014-03-12 17:01:48
Documents
1
Period of Report
2014-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 5136
  Complete submission text file 0001179110-14-005102.txt   7399
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
COLUMBIA LABORATORIES INC (Issuer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 577 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address 577 CHIPETA WAY SALT LAKE CITY UT 84108 (862) 261-7000
COVENTRY ACQUISITION, LLC (Reporting) CIK: 0001496606 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-10352 | Film No.: 14688354

Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Reporting) CIK: 0001578845 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-10352 | Film No.: 14688355
SIC: 2834 Pharmaceutical Preparations